Asthma and respiratory immunology Flashcards

1
Q

What are the cardinal features of asthma? (3)

A

-Atopy / allergen sensitisation
-Reversible airflow obstruction
-Airway inflammation
Eosinophilia
Type 2 - lymphocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What type of immune cells do you see infiltrating asthmatic airways?

A

Eosinophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the pathogenesis of allergic asthma

A

-An allergen gets introduced into the airway bronchial epithelium which sensitizes it causing, inflammation and remodeling.
-Recruitment of inflammatory cells (mostly eosinophils) leads to increase in mucous secreting goblet cells.
-Amount of MATRIX and MUSCLE CELL SIZE then increase.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why are only some people who are sensitised develop the disease of asthma?

A

Due to genetic susceptibility to asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Circled genes are more expressed in asthma patients

  • What does this show about the genetic cause of asthma?
A

That it’s a multigene disorder and is polyfactorial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does MHC stand for and what is MHC class II and its function

A

Major histocompatibility complex:
-It is present on the surface of certain immune cells, such as dendritic cells, B cells, and macrophages

-Presents antigens to T helper cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How does type 2 immunity reaction come about in allergic asthma? (3 STEPS)

A
  • Patients with asthma have exposure to inhaled allergen
  • This allergen binds to lung dendritic cells and are carried via MHC class II to mediastinal lymph nodes
  • Naive T cells in nodes differentiate into Th2 cell which secretes IL4, 5 and 13
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does IL-4 do?

A

Helps conversion of B plasma cells to secrete IgE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does IL-5 do?

A

IL-5 recruits eosinophils into airways and promotes their survival- causing eosinophilia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What does IL-13 do?

A

Involved in mucous production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

If a patient is already sensitised to allergen- what happens if they’re exposed to it again?

A
  • There’s an allergic immune response
  • IgE recognises circulating antigen and binds to mast cells
  • Mast cells degranulate and release histamines, cytokines, chemokines, growth factors, enzymes, eicosanoids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do we test for allergic sensitisation? (2) (what reaction to we look for)

A

-Blood tests for specific IgE antibodies
-Allergy skin prick tests, look for WHEAL AND FLARE REACTION.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How do we test for eosinophilia? (3)

A
  • Blood eosinophil count when stable → ≥300 cells/mcl is abnormal
  • Induced sputum eosinophil count: ≥2.5% eosinophils is abnormal
  • Exhaled nitric oxide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What objective tests are done to diagnose asthma? (3)

A
  • Airway obstruction on spirometry- FEV1/FVC ratio <0.7
  • Reversible airway obstruction- bronchodilator reversibility ≥12%
  • Exhaled NO (FeNO) >35ppb (children), >40ppb (adults)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the 3 areas of asthma management?

A

-Reduce airway eosinophilic inflammation
-Acute symptomatic relief
-Treat severe asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do we reduce airway eosinophilic inflammation?

A
  • Inhaled corticosteroids- target and reduce eosinophilic inflammation
  • Leukotriene receptor antagonists- can reduce type 2 inflammation
17
Q

How do we give acute symptomatic relief?

A
  • Beta-2 agonists (smooth muscle relaxation)
  • Anticholinergic therapies (smooth muscle relaxation)
18
Q

How do we treat severe asthma?

A

Steroid sparing therapies

  • Biologics targeted to IgE e.g. anti-IgE antibody
  • Biologics targeted to airway eosinophils e.g. anti-interleukin-5 antibody and anti-interleukin-5 receptor antibody
19
Q

Why do we use corticosteroids? (what things do they do?) (2)

A
  • Reduce eosinophil numbers through apoptosis
  • Reduce mast cell numbers
20
Q

How do we measure adherence objectively?

A

Electronic adherence monitoring

21
Q

What is the order of treatment for asthma patients?

22
Q

How do we treat acute asthma attacks?

A
  • With systemic high dose steroids like prednisolone
  • Inhaled steroids in maintenance therapy isn’t good enough
23
Q

How does anti-IgE antibody therapy work?

A
  • Binds and captures circulating IgE- prevents its interaction with mast cells and basophils to stop allergic cascade
  • IgE production can decrease with time when patients given anti-IgE Ab
24
Q

What is Omalizumab?

A
  • The commonly used anti-IgE antibody given as subcutaneous injections
  • Is very expensive
  • Is effective at reducing exacerbations compared to placebo
25
When is omalizumab used?
Severe, persistent allergies (IgE mediated) asthma in patients ≥6 years who need continuous or frequent treatment with oral corticosteroids Have to have optimised standard therapy with good adherence with no response
26
What serum IgE level is Omalizumab prescribed for?
Total serum IgE between 30-1500
27
What is Mepolizumab?
- Anti-IL5-antibody - Reduces IL-5 effect, reducing eosinophilic inflammation in severe eosinophilic asthma
28
When is Mepolizumab trialed?
Blood eosinophils ≥300 cells/mcl in the last 12 months At least 4 exacerbations requiring oral steroids in the last 12 months